Tokenizing Pharma & Healthcare Assets
Blockchain technology has been seen making headlines over the past decade, and its implementation has been controversial in many sectors. On paper, blockchain brings a lot of benefits to security-oriented uses. However, unlike some sectors where a mistake may not come with a high cost, there is no margin for error when it comes to implementation within the pharma & healthcare industry and that is the main reason experts are still reluctant to implement it.
As a technology-based startup, Trade Pharma Network has been actively involved technological-driven innovations impacting pharma & healthcare through our both existing & upcoming solutions. Indeed, technology is in our DNA and Blockchain & Crypto is clearly one of the techs we are relying on the most and we are tremendously hard working towards a massive Blockchain adoption & assets tokenization in the industry and how to get ahead in driving for this inevitable trend.
To meet this ultimate goal, we are offering our pharma & healthcare customers a Blockchain-based platform dedicated to 3 key strategic market segments i.e. large companies & international corporations, small & medium-size businesses and emerging innovative businesses where blockchain is a crucial component and critical to their success. Also, we have opted for Ethereum as a programming platform & general cryptonetwork that can be used for almost any purpose.
Why tokenizing pharma & healthcare assets?
The bottom line is that pharma & healthcare companies are largely unaware or unclear how to engage in this complex investment landscape, and investors are unfamiliar with the specific healthcare needs.
Tokenization is nothing more digitizing ownership of real-world assets and companies into security tokens. Real world assets are difficult to subdivide equally and physically transfer.
And like any given asset, digitizing pharma & healthcare asset ownership into security tokens and putting on the blockchain provides the many advantages such as liquidity increasing, tokenized securities can be easily moved and are independently controlled, it provides the ability to reach the global free market of accredited & non-accredited individuals around the world who can now have access to invest in an offering and play a bigger role in it’s success, it allows for automated smart compliance to be programmed into token’s digital structure for domestic & international security laws compliance, Lowers fees and enables faster issuance on the primary by removing middlemen like bankers etc.
TokenZu™: our Blockchain & Crypto solution
Therefore, on top of our pharmaceuticals trading platform (Zefir™) & supply chain management solution (SCM Tech — 4™) allowing all the pharmaceutical supply chain members to interact more efficiently & securely, we are also, alongside our crypto partners, offering to our customers a Blockchain & Crypto based solution, TokenZu™, a Tokenization as a Service (TaaS) platform that operates with smart contracts & distributed ledger blockchain technology in conjunction with a real estate security token standard compliant with ST-20 interface.
TokenZu™ solution helps our customers tokenize their pharma & healthcare digital assets via Blockchain which represent an interesting opportunity to bring much more benefits to security-oriented uses but also to introduce liquidity into the market. Indeed, funding gap in new drug development is only one example of the shortfall required to meet the challenges in today’s landscape. The UN estimates it will cost $3.9 trillion to meet the needs of the Sustainable Development Goals (SDGs) in developing countries alone. Current levels of public and private funding cover only $1.4 trillion, leaving significant room for innovation.
Starting with us: our triple-token model
As a Blockchain-powered marketplace, it is important to mention that we are leveraging the benefits that are inherent in our combined 3 tokens that comprises a utility tokens (TXP), a reward token (BUTY) and a security tokens (TRP-N). Indeed, two years after launching our two-token model (TTM), our cryptonomic thinking has dramatically evolved and we have successfully upgraded our former TTM to a triple-token model for higher-yield and more stable decentralized network.
It is complex piece of engineering as each of the three involved tokens performs a specific different function within the Network. They also interact with each other as an integrated system. That been said, we will be making sure to keep all our users & investors informed are well informed of evolution and to advise each and all of them on how to use them in the most beneficial way.
In conclusion
Very exciting things are happening both with respect to the kind of projects being pursued as mentioned above, with pharma & Biotech and healthcare organizations now coalescing around the Trade Pharma Network vision. We are looking forward to keeping you updated.
As a result of this push, a holistic platform is helpful to provide asset class specific, customized service and build confidence with the principle stakeholder of each niche asset class be tokenized. This is especially important in the early years of transitioning to any new technology paradigm. Blockchain and tokenization is no different. As the year of the security token unfolds we look forward to seeing the security tokenization ecosystem continue to spread and cover pharma & healthcare sector.
The Trade Pharma Network team
